Form 4: Nutex Health Insider Buys Shares, Corrects RSU Filing

Nutex Health President Warren Hosseinion acquired common stock and corrected a previous filing regarding restricted stock units.

Summary

• Warren Hosseinion, President and Director of Nutex Health Inc. (NUTX), acquired 252 shares of common stock.
• The common stock acquisition occurred on March 19, 2026, at a price of $94.0723 per share.
• Following this transaction, Mr. Hosseinion directly beneficially owns 7,765 shares of common stock.
• The filing also corrects the number of restricted stock units (RSUs) beneficially owned, now stating 12,465 RSUs are directly beneficially owned.
• This RSU correction relates to a grant reported in a Form 4 filed on March 11, 2026, for a transaction dated March 10, 2026.
• The corrected RSUs have a conversion price of $0, become exercisable on March 1, 2027, and expire on March 1, 2029.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to the insider purchase of common stock, which typically signals management confidence, despite the administrative correction of RSU reporting.

Positives

• A key insider, President and Director Warren Hosseinion, acquired 252 shares of common stock, indicating confidence in the company's future prospects.

Future Outlook

This Form 4 primarily reports past transactions and an administrative correction, and does not contain explicit forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a President and Director, often signals management's belief in the company's undervaluation or strong future prospects. This activity can be a positive indicator for investors, especially in the healthcare sector where strategic insights from leadership are highly valued.

Comparison to Industry Standards

• NA

Related Party Transactions

• Acquisition of 252 shares of common stock by Warren Hosseinion, President and Director of Nutex Health Inc.
• Correction of previously reported Restricted Stock Units (RSUs) beneficially owned by Warren Hosseinion, President and Director of Nutex Health Inc.

Stakeholder Impact

• Shareholders: May interpret the insider purchase as a positive signal of management's confidence in the company's valuation and future performance.

Next Steps

• The Restricted Stock Units held by Warren Hosseinion are scheduled to become exercisable on March 1, 2027.

Key Dates

Recommendation

The acquisition of common stock by a key insider, the President and Director, suggests management confidence in Nutex Health's future. However, this Form 4 primarily reports a transaction and an administrative correction, lacking broader financial or strategic updates to warrant a stronger recommendation. Investors should consider this insider activity alongside comprehensive financial analysis.

Keywords

Nutex Health, NUTX, insider trading, Form 4, stock acquisition, restricted stock units, RSU, beneficial ownership